Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia
NCT05215015
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
BIOLOGICAL:
Anti-CD33/CLL1 CAR-NK Cells
Sponsor
Wuxi People's Hospital
Collaborators
[object Object]